BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Alexion Appoints Judith A. Reinsdorf, J.D., to its Board of Directors

  Ms. Reinsdorf is an accomplished executive with a strong background in corporate governance and broad expertise in managing corporate and legal affairs for large public companies.

  February 5, 2018

   · 

  4 min read
• Biotech Beach

  Strathspey Crown Wins U.S. Patent for Titration of Phenotypic (DNA) Expression

  The genotype is the set of genes in our DNA, which is responsible for a particular trait.

  February 5, 2018

   · 

  3 min read
• Policy

  Trethera Announces FDA Clearance of Investigational New Drug Application for TRE-515

  Under this IND, Trethera plans to initiate a Phase 1 study designed to evaluate the safety, pharmacokinetics, and pharmacodynamics of TRE-515 as well as validate several biomarkers in relapsed and/or refractory MDS patients who have no available alternative therapy.

  February 5, 2018

   · 

  3 min read
• Drug Development

  Cryoport to Provide TiGenix With Cutting Edge Cold Chain Logistics for Clinical Trial of SEPCELL for the Treatment of Sepsis

  TiGenix aims to recruit 180 patients in at least 50 centers for the randomized double-blind placebo controlled SEPCELL study.

  February 5, 2018

   · 

  4 min read
• Policy

  Jupiter Orphan Therapeutics in Process to Submit IND for MPSI and Other Indications

  This will be the first of several anticipated IND submissions in 2018 utilizing JOT’s platform product, JOTROL.

  February 5, 2018

   · 

  5 min read
• Teewinot Life Sciences Corporation’s Subsidiary, Teewinot Technologies, Ltd., Announced Today: Grant of a New Patent With Broad Claims to Biosynthetic Production of Cannabinoids

  The claims of the ‘292 patent cover biosynthetic production of cannabinoids and cannabinoid analogs.

  February 5, 2018

   · 

  2 min read
• 

  Lone Star Bio

  Seisa Medical Closes $42.5MM Recapitalization and Acquisition Line

  The cash will be used to pay fees and expenses associated with the transaction, fund a dividend to shareholders and complete acquisitions.

  February 5, 2018

   · 

  2 min read
• Policy

  Kowa Pharmaceuticals America, Inc. Announces Agreement with Apotex to Resolve All Outstanding Litigation Related to Livalo (pitavastatin)

  Plaintiffs had brought suit against Apotex for patent infringement based on the filing of Apotex’s ANDA seeking Food and Drug Administration (FDA) approval to market 1 mg, 2 mg, and 4 mg pitavastatin calcium tablets, generic to Livalo.

  February 5, 2018

   · 

  3 min read
• Drug Development

  OncBioMune Signs Letter of Intent to Initiate Phase II Trial of ProscaVax for Advanced Prostate Cancer With Urology Clinics of North Texas

  Dr. James S. Cochran, M.D., D.A.B.U., F.A.C.S., UCNT Medical Director, has agreed to serve as the trial’s Principal Investigator.

  February 5, 2018

   · 

  4 min read
• Business

  BIOLIFE4D Signs Laboratory Service Agreement With Northwestern University

  Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities,.

  February 5, 2018

   · 

  3 min read